Changes

no edit summary
Line 282: Line 282:  
|
 
|
 
|-
 
|-
 +
|Low grade gliomas, WHO grade I-II                     
 +
|-
 +
|
 +
|Pilocytic astrocytoma
 +
|'''Gain:''' 5, 7, 6, 11<br>
 +
'''Loss:''' 1, 2, 3, 13, 14, 16, 17, 19
 +
|'''Fusion:''' KIAA1549-BRAF fusion (via 3'BRAF duplication), other BRAF partners reported; NTRK fusions (rare)<br>
 +
'''Mutation:''' FGFR1
 +
|Aneuploidy is more predominant in adult PA; Infratentorial tumors are more likely to have BRAF fusions/dup and be wildtype for BRAF mutations; Extra-cerebellar tumors are more likely to be BRAF V600E+, but negative for fusion; Surgical resection can be curative
 +
|PMID: 24470550; PMID:26378811; PMID: 25664944; PMID:26992069
 +
|-
 +
|
 +
|Pleomorphic xanthoastrocytoma (PXA)
 +
|'''Gain:''' 7, 2, 5, 21, 20, 12, 15<br>
 +
'''Loss:''' monosomy 9 / 9p deletion most common, 22, 14, 13, 10<br>
 +
'''CN-LOH:''' 9p, 22
 +
|'''Loss:''' homozygous loss CDKN2A/B<br>
 +
Mutation: BRAF V600E
 +
|Adults and pediatric tumors show similar CNVs; CDKN2A/CDKN2B loss may correlate with anaplastic histology
 +
|PMID:23442159; PMID:28181325